$31.70
-0.91
(-2.79%)
DRUG Performance Snapshot
1-Week Chg
1-Month Chg
3-Month Chg
6-Month Chg
1-Year Chg
Year-To-Date Chg
Beta 1-Year
8.34Beta 5-Year
-4.86Volatility (10-Day)
3.66%DRUG Technicals
DRUG Financials
(CAD)
2024 Q4
Y/Y CHANGE
Cash and equivalents
$57.90M
756.25%Total assets
$58.40M
747.95%Total liabilities
$571.59K
-33.08%Total investments
$0
0%Shareholders' equity
$57.83M
858.53%Book value per share
$9.38
497.39%
(CAD)
2024 Q4
Y/Y CHANGE
Revenue
$0
0%Net income
$49.61K
102.95%Operating expense
$1.62M
-4.38%Gross profit
$0
0%EBITDA
$71.14K
104.27%Earnings per share
$0.01
102.27%
(CAD)
2024 Q4
Y/Y CHANGE
Net change in cash
$50.55M
90232.60%Cash from operations
-$1.49M
-81.78%Cash from investing
$0
0%Cash from financing
$52.04M
5826.92%Free cash flow
-$1.49M
-81.78%Free cash flow per share
-$0.24
-13.08%
(CAD)
2024 Q4
Y/Y CHANGE
Market capitalization
$162.96M
2452.88%Enterprise value
$159.01M
12041.97%Shares outstanding
4.52M
1.35%Profit margin
-
-Gross margin
-
-EBITDA margin
-
-
(CAD)
2024 Q4
Y/Y CHANGE
Dividend yield
0%
0%Dividends per share
$0
0%Dividend growth
-
-Payout ratio
0%
0%Coverage ratio
-
-Current ratio
126.15
1475.71%
